Press Release 

DCAT 2009-2010 Board of Directors To Take Office November 1

Robbinsville, NJ, October 28, 2009 – DCAT is pleased to announce that the slate of candidates for the 2009-2010 Board of Directors was approved by member company designated contacts. Joe Principe, vice president, global business development with Piramal Healthcare will serve as president, taking office on November 1, along with the other elected board members.

Former DCAT President Jim Martin, executive director, global external supply at Schering-Plough will join the Executive Committee’s Advisory Council.

Tyson Popp, vice president research and development at West Pharmaceutical Services, Inc. joins the officers of the Executive Committee as vice president, and David McCleary, president of Custopharm Inc. replaces him as vice president - associated technologies.

Completing their three-year-term on the Board of Directors are Kim Cauchy, director, global sourcing with Hospira, and Michael Morgan, established products, global products team leader at Pfizer, Inc.
Completing her term on the DCAT Advisory Council is Lynda M. Doyle, director of Business Development at DSM Nutritional Products, Inc. Doyle served as the association's president in 2005-2006.

Joining the Board for the first time are Steven DeSalvo, director, contract manufacturing at FIS; Sally Langa, vice president, business development with Patheon Inc.; Pam Tyler, purchasing manager at DPT Laboratories, Ltd.; and Malcolm Rosenthal, executive vice president at Austin Chemical Company, Inc.

Below is the full slate of newly elected Board of Directors:

Officers of the Executive Committee of the Board of Directors (1 Year Term):
President: Joseph Principe, Vice President, Global Business Development, Piramal Healthcare
Sr. Vice President: Bob Kanuga, Executive Director, External Manufacturing Operations,
   Merck & Co., Inc.
Finance Officer: Joan Connolly, Associate Vice President of Strategies & Operations,
   ImClone Systems Inc.
Vice President: Tyson Popp, Vice President Research & Development, West Pharmaceutical
   Services, Inc.

Vice Presidents of the Executive Committee of the Board of Directors (1 Year Term):
Associated Technologies Industry Segment Vice President: David McCleary, President,
   Custopharm, Inc.
Biotechnology Industry Segment Vice President: Narayan Balachandran, Director, Global
   Strategic Sourcing, Amgen Inc.
Chemical Industry Segment Vice President: Donald LaFerle, President, Sales & Marketing,
   IRIX Pharmaceuticals, Inc.
Nutrition & Health Industry Segment Vice President: Janice K. Binger, President, Natural
   Health & Nutrition Division, Archer Daniels Midland
Pharmaceutical Industry Segment Vice President: Lyra Myers, Global Chemical Category
   Manager, Stiefel Laboratories, a GSK Company

Board of Directors (3 Year Term):
Stephen DeSalvo, Director, Contract Manufacturing, Fabbrica Italiana Sintetici
Sally Langa, Vice President, Business Development, Patheon Inc.
Pam Tyler, Purchasing Manager, DPT Laboratories, Ltd.
Christopher Rayfield, Vice President, Sales & Marketing, ACIC Fine Chemicals Inc.
Malcolm Rosenthal, Executive Vice President, Austin Chemical Company, Inc.
Kevin Weithman, Business Development Manager, The Dow Chemical Company


About DCAT
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical, nutritional and related industries.

Erin Sanders
DCAT Communications Coordinator